Vanguards of Health Care by Bloomberg IntelligenceVanguards of Health Care by Bloomberg Intelligence

Vericel Advances Use of Cell Therapies

View descriptionShare

Vericel acquired a hidden gem in cartilage repair that other companies had written off, and developed it into a high-growth product that could potentially address a $4 billion market. In this episode of the Vanguards of Health Care podcast, Vericel CEO Nick Colangelo sits down with Matt Henriksson, Bloomberg Intelligence analyst, to talk about how MACI took over as the market leader for cartilage repair in the knee and its potential to do so for the ankle. Colangelo also discusses why the company built a diversified portfolio and how NexoBrid complements its Epicel platform to fill out the company’s burn-care offerings.

  • Facebook
  • Twitter
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Vanguards of Health Care by Bloomberg Intelligence

    42 clip(s)

Vanguards of Health Care by Bloomberg Intelligence

Vanguards of Health Care is a series of exclusive conversations with management teams and thought le 
Social links
Follow podcast
Recent clips
Browse 42 clip(s)